Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Neurofibromatosis 2 × Endostatins × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 11 Nasopharyngeal Carcinoma 5 Nasopharyngeal Neoplasms 3 Colorectal Neoplasms 3 Breast Neoplasms 3 Uterine Cervical Neoplasms 2 Sarcoma 2 Recurrence 2 Unresectable Non-small Cell Lung Cancer 1 Squamous Non-small Cell Lung Cancer 1 Squamous Non-Small Cell Lung Cancer SqNSCLC 1 Optic Nerve Glioma 1 Neuroma, Acoustic 1 Neurofibromatosis 2 1 Neuroblastoma 1 Neoplasms 1 Melanoma 1 Lymphoma, T-Cell 1 Lung Neoplasms 1 Locally Advanced Squamous Non-small Cell Lung Cancer 1 Head and Neck Neoplasms 1 Glioblastoma 1 Gastrointestinal Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Carcinoma, Hepatocellular 1 Advanced Pancreatic Cancer 1 Adenoma, Islet Cell 1

Interventions

Everolimus 3 Bevacizumab 3 neratinib 1 icotinib 1 emvododstat 1 brigatinib 1 Vascular Endothelial Growth Factor A 1 Sunitinib 1 Sirolimus 1 Lapatinib 1 Endostatins 1 Axitinib 1 Aspirin 1 AZD 6244 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02104323 2017-02-09

Endostatin

Beijing Tiantan Hospital

Phase 2 Completed

Neuroma, Acoustic, Neurofibromatosis 2

Data powered by HemOnc (CC BY 4.0) Colophon ⚡